Satisfaction of Parkinson patients, caregivers and clinicians after STN-DBS and its predictors
Objective: To evaluate and compare patients’ and caregivers’ satisfaction with subthalamic nucleus (STN)-DBS and to identify preoperative indicators, which can prove valuable in defining postoperative…A Review of Electronic Devices to Track Medication Adherence in Parkinson’s Disease
Objective: The current study set out to compare existing electronic devices (EDs) for tracking medication adherence (MA) and to provide a framework for device selection…Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)
Objective: Describe the rationale and process for acquiring speech data to contribute to increasing accessibility to speech recognition for patients with PD. Background: Disordered speech…Preliminary validation of an educational handbook for Parkinson’s disease patients in Brazil
Objective: To describe the development and preliminary validation of an educational handbook for Parkinson’s disease (PD) patients. Background: PD is a progressive, chronic and heterogeneous…Patient-Reported Impact of Standard-of-Care: Change in Symptoms Following Dopamine Initiation and Deep Brain Stimulation
Objective: The goal of this study was to describe changes in patient-reported symptoms following initiation of standard-of-care treatment strategies in Parkinson’s disease (PD). Background: A…The role of community engagement and involvement in Parkinson’s disease research: a case study from Africa
Objective: Using a case study from Africa to understand the potential role of community engagement and involvement (CEI) in future research on Parkinson’s disease (PD).…Evaluating Patients’ Preferences for Parkinson’s Disease Treatments
Objective: To identify patients’ preferences for attributes of oral medications that are added to levodopa or levodopa/carbidopa (LD/CD) regimens to reduce OFF-time for Parkinson’s disease…Modeling of the Placebo Response in Parkinson’s Disease
Objective: The objective of this study was to investigate the predictability of the placebo response in Parkinson's disease (PD) subjects participating in a randomized clinical…Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II clinical trial
Objective: To design a clinical trial to test the concept that the immune system is integral in the progression of Parkinson’s disease (PD) and establish…Efficacy of a 6-week brisk walking program in improving non-motor symptoms in people with Parkinson disease – a randomized controlled trial
Objective: To examine whether the brisk walking program would be effective in alleviating non-motor symptoms, and improving sleep quality and health-related quality-of-life (HRQoL) in people…
- « Previous Page
- 1
- …
- 319
- 320
- 321
- 322
- 323
- …
- 338
- Next Page »